[EXECUTION COPY SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement (1) WP X WPP X, Purchasers Purchaser (2) IDG Fund IDG Investors Sellers Seller Parties Party Sellers and Purchasers are collectively referred to herein as the WHEREAS: 1. Company China Biologic Products, Inc. (the 2. Shares The Company is listed on NASDAQ. As of April 23, 2012, a] []
[EXECUTION COPY SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement (1) WP X WPP X, Purchasers Purchaser (2) IDG Fund IDG Investors Sellers Seller Parties Party Sellers and Purchasers are collectively referred to herein as the WHEREAS: 1. Company China Biologic Products, Inc. (the 2. Shares The Company is listed on NASDAQ. As of April 23, 2012, a] []
[April 26, 2012 To: KKR China Healthcare Investment Limited c/o KKR Asia Limited Dear Sirs, Re: Lock-Up Agreement dated April 12, 2012 Lock-Up Agreement We refer to the Lock-Up Agreement dated April 12, 2012 (the “ mutatis mutandis The provisions of Sections 5, 6 and 7 of the Lock-Up Agreement are hereby incorporated by reference into this letter and will]
[April 26, 2012 To: KKR China Healthcare Investment Limited c/o KKR Asia Limited Dear Sirs, Re: Lock-Up Agreement dated April 12, 2012 Lock-Up Agreement We refer to the Lock-Up Agreement dated April 12, 2012 (the “ mutatis mutandis The provisions of Sections 5, 6 and 7 of the Lock-Up Agreement are hereby incorporated by reference into this letter and will]
[April 26, 2012 To:R China Healthcare Investment Limited c/oRia Limited Dear Sirs, Re: Lock-Upreementted April 12, 2012 Lock-Upreement We refer to the Lock-Upreementted April 12, 2012 (the mutatis mutandis The provisions of Sections 5, 6 and 7 of the Lock-Upreement are herebyorporated by reference into this letter and will apply]
[April 26, 2012 To:R China Healthcare Investment Limited c/oRia Limited Dear Sirs, Re: Lock-Upreementted April 12, 2012 Lock-Upreement We refer to the Lock-Upreementted April 12, 2012 (the mutatis mutandis The provisions of Sections 5, 6 and 7 of the Lock-Upreement are herebyorporated by reference into this letter and will apply]
[SCHEDULE 13D (Rule 13d-101) (Amendment No. 3)* Origin Agritech Limited (Name of Issuer) Ordinary Shares, no par value (Title of Class of Securities) G67828106 (CUSIP Number) With a copy to: Dr. HAN Gengchen c/o Origin Agritech Limited 21 Sheng Ming Yuan Road Changping District Beijing, China 102206 with a copy to: Andrew D. Hudders, Esq. Golenbock Eisemen Assor Bell &]
[SCHEDULE 13D (Rule 13d-101) (Amendment No. 3)* Origin Agritech Limited (Name of Issuer) Ordinary Shares, no par value (Title of Class of Securities) G67828106 (CUSIP Number) With a copy to: Dr. HAN Gengchen c/o Origin Agritech Limited 21 Sheng Ming Yuan Road Changping District Beijing, China 102206 with a copy to: Andrew D. Hudders, Esq. Golenbock Eisemen Assor Bell &]
[Execution Copy LOCK-UP AGREEMENT among KKR CHINA HEALTHCARE INVESTMENT LIMITED and COMPANY LIMITED Golden Meditech STEM CELL (BVI) and LIMITED Golden Meditech HOLDINGS ________________________________ Dated April 12, 2012 ________________________________ Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page SECTION 1 INTERPRETATION 1 SECTION]
